REATA PHARMACEUTICALS INC Annual Share-based Payment Arrangement, Expense in USD from 2014 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Reata Pharmaceuticals Inc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2014 to 2022.
  • Reata Pharmaceuticals Inc Share-based Payment Arrangement, Expense for the quarter ending June 30, 2023 was $20.4M, a 46.9% increase year-over-year.
  • Reata Pharmaceuticals Inc Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2023 was $87.8M, a 51% increase year-over-year.
  • Reata Pharmaceuticals Inc annual Share-based Payment Arrangement, Expense for 2022 was $58.7M, a 3.39% increase from 2021.
  • Reata Pharmaceuticals Inc annual Share-based Payment Arrangement, Expense for 2021 was $56.8M, a 1.44% decline from 2020.
  • Reata Pharmaceuticals Inc annual Share-based Payment Arrangement, Expense for 2020 was $57.6M, a 118% increase from 2019.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $58.7M +$1.93M +3.39% Jan 1, 2022 Dec 31, 2022 10-K 2023-02-24
2021 $56.8M -$827K -1.44% Jan 1, 2021 Dec 31, 2021 10-K 2023-02-24
2020 $57.6M +$31.3M +118% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-24
2019 $26.4M +$15.8M +150% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 $10.6M +$4.02M +61.6% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-01
2017 $6.53M +$4.16M +176% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-19
2016 $2.37M +$292K +14.1% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
2015 $2.08M +$552K +36.2% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-02
2014 $1.52M Jan 1, 2014 Dec 31, 2014 10-K 2017-03-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.